{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-21T23:44:15.859919+00:00","published_at":"2026-10-21T04:48:59.447603+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:bs59hh1rciym5","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-26","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:denise-carter","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:1cacf7a36f0c2e4250409be1b2f3cb2ad2ea7e91e269f0e61add98a0a0522895"],"summary":"Denise Carter executive of Quoin Pharmaceuticals, Ltd., effective 2026-03-26.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:pildxtknj8wf","event_type":"CFO_CHANGED","effective_at":"2026-03-26","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:sally-lawlor","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:ad75257c1f437c2f35b4430bd888e34395fec5a3192d9c22aad219eb174aa59f"],"summary":"Sally Lawlor executive of Quoin Pharmaceuticals, Ltd., effective 2026-03-26.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:o7yadb1x1ptuh","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:denise-carter","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"Denise Carter seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hz3ouyhznyg6","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:james-culverwell","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"James Culverwell seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:q2xjtlghje4z","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:joseph-cooper","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"Joseph Cooper seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1kjas1k1bmrxm0","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:michael-sember","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"Michael Sember seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:x4demv1buapbx","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:natalie-leong","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"Natalie Leong seat on Quoin Pharmaceuticals, Ltd., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1f4str63f228e","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:committee:quoin-pharmaceuticals-ltd:audit-chair-compensation","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"Audit · Chair; Compensation committee of Quoin Pharmaceuticals, Ltd., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1x3gc7oz3zg58","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:james-culverwell","alpha:committee:quoin-pharmaceuticals-ltd:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"James Culverwell member of Audit · Chair; Compensation, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:11ojlx7vmkvn","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:committee:quoin-pharmaceuticals-ltd:audit-nominating-and-governance","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"Audit; Nominating and Governance committee of Quoin Pharmaceuticals, Ltd., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15gn1ycuhfg96","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:joseph-cooper","alpha:committee:quoin-pharmaceuticals-ltd:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"Joseph Cooper member of Audit; Nominating and Governance, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3xub871npn2sl","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:committee:quoin-pharmaceuticals-ltd:audit-nominating-and-governance-chair","alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"Audit; Nominating and Governance · Chair committee of Quoin Pharmaceuticals, Ltd., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1kbqyae1ny1bgw","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:natalie-leong","alpha:committee:quoin-pharmaceuticals-ltd:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9"],"summary":"Natalie Leong member of Audit; Nominating and Governance · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:5","subject_id":"alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:denise-carter","object_label":"Denise Carter","object_source_name_forms":[],"value":"Denise Carter: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:denise-carter","name":"Denise Carter"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quoin Pharmaceuticals, Ltd. DEF 14A 2025-07-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","source_date":"2025-07-17","retrieved_at":"2026-04-28T23:00:07.354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-17","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:6","subject_id":"alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-culverwell","object_label":"James Culverwell","object_source_name_forms":[],"value":"James Culverwell: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-culverwell","name":"James Culverwell"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quoin Pharmaceuticals, Ltd. DEF 14A 2025-07-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","source_date":"2025-07-17","retrieved_at":"2026-04-28T23:00:07.354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-17","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:7","subject_id":"alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:joseph-cooper","object_label":"Joseph Cooper","object_source_name_forms":[],"value":"Joseph Cooper: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:joseph-cooper","name":"Joseph Cooper"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quoin Pharmaceuticals, Ltd. DEF 14A 2025-07-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","source_date":"2025-07-17","retrieved_at":"2026-04-28T23:00:07.354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-17","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:8","subject_id":"alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-sember","object_label":"Michael Sember","object_source_name_forms":[],"value":"Michael Sember: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-sember","name":"Michael Sember"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quoin Pharmaceuticals, Ltd. DEF 14A 2025-07-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","source_date":"2025-07-17","retrieved_at":"2026-04-28T23:00:07.354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-17","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:9","subject_id":"alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:natalie-leong","object_label":"Natalie Leong","object_source_name_forms":[],"value":"Natalie Leong: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:natalie-leong","name":"Natalie Leong"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quoin Pharmaceuticals, Ltd. DEF 14A 2025-07-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","source_date":"2025-07-17","retrieved_at":"2026-04-28T23:00:07.354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-17","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:10","subject_id":"alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:denise-carter","object_label":"Denise Carter","object_source_name_forms":[],"value":"Denise Carter: Chief Operating Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:denise-carter","name":"Denise Carter"},"title":"Chief Operating Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-26","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-26","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:1cacf7a36f0c2e4250409be1b2f3cb2ad2ea7e91e269f0e61add98a0a0522895","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:48.077136+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26T00:00:00+00:00","effective_from":"2026-03-26","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a:leadership_role:11","subject_id":"alpha:company:3a18fa2d-f338-4f33-a56d-2d6ae2c7f12a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sally-lawlor","object_label":"Sally Lawlor","object_source_name_forms":[],"value":"Sally Lawlor: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sally-lawlor","name":"Sally Lawlor"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-26","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-26","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:ad75257c1f437c2f35b4430bd888e34395fec5a3192d9c22aad219eb174aa59f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:48.571205+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26T00:00:00+00:00","effective_from":"2026-03-26","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:9b21d6bc5d23b6d88be83349bf0b296bd63281ec25cdd55e97f7518c9df9f8a9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quoin Pharmaceuticals, Ltd. DEF 14A 2025-07-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","source_date":"2025-07-17","retrieved_at":"2026-04-28T23:00:07.354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1cacf7a36f0c2e4250409be1b2f3cb2ad2ea7e91e269f0e61add98a0a0522895","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:48.077136+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ad75257c1f437c2f35b4430bd888e34395fec5a3192d9c22aad219eb174aa59f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNRX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:48.571205+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.831,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.882,"cross_source_agreement":0.75,"temporal_completeness":0.467},"diagnostics":{"published_claims":22,"factual_claims":22,"claims_with_linked_evidence":22,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":15,"temporal_claims_with_valid_from":7,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-21T04:48:59.447603+00:00","observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":"2026-10-21T04:48:59.447603+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/quoin-pharmaceuticals-ltd/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/quoin-pharmaceuticals-ltd?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}